Medicure (TSXV:MPH) Price-to-Tangible-Book

: 1.31 (As of Today)

View and export this data going back to 1999. Start your Free Trial

As of today (2024-04-24), Medicure's share price is C$0.99. Medicure's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was C$0.75. Hence, Medicure's Price to Tangible Book Ratio of today is 1.31.

The historical rank and industry rank for Medicure's Price-to-Tangible-Book or its related term are showing as below:

TSXV:MPH' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.17 Med: 2.05 Max: 20.14
Current: 1.32

During the past 13 years, Medicure's highest Price to Tangible Book Ratio was 20.14. The lowest was 1.17. And the median was 2.05.

TSXV:MPH's Price-to-Tangible-Book is ranked better than
74.91% of 873 companies
in the Drug Manufacturers industry
Industry Median: 2.32 vs TSXV:MPH: 1.32

A closely related ratio is called PB Ratio. As of today, Medicure's share price is C$0.99. Medicure's Book Value per Sharefor the quarter that ended in Dec. 2023 was C$1.91. Hence, Medicure's P/B Ratio of today is 0.52.

Medicure Price-to-Tangible-Book Historical Data

The historical data trend for Medicure's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Annual Data

Trend

May14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.74

4.76

2.23

1.44

1.86

Medicure Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.55	1.44	1.42	1.82	1.86

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicure Price-to-Tangible-Book Distribution

For the Drug Manufacturers industry and Healthcare sector, Medicure's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Medicure's Price-to-Tangible-Book falls into.

Medicure Price-to-Tangible-Book Calculation

Medicure's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.99	/	0.753
	=	1.31

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Medicure Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Medicure's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicure (TSXV:MPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

MCUJF:USA NGQ1:Germany

Address

2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.medicure.com

Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

Medicure (TSXV:MPH) Headlines

No Headlines